Skip to main content
Premium Trial:

Request an Annual Quote

BG Medicine Closes $40M Round of Financing

NEW YORK (GenomeWeb News) – BG Medicine said today that it has raised $40 million in a Series D financing.
 
The privately held molecular diagnostics firm said the funding would enable it to complete development and commercialization of its first two diagnostic products and continue discovery and development of additional product candidates.
 
Investors in the round included Legg Mason Capital Management, GE Asset Management, and Smallcap World Fund. They joined current investors Flagship Ventures, Glide Healthcare Partners, Humana, and Stelios Papadopoulos.
 
Leerink Swann acted as placement agent for the financing.
 
Waltham, Mass.-based BG last year filed for an initial public offering on the Euronext Amsterdam Exchange. However, the firm withdrew the offering earlier this year, citing “current market conditions.”
 

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.